SpringWorks Therapeutics Correlations
| SWTXDelisted Stock | USD 46.99 0.00 0.00% |
The current 90-days correlation between SpringWorks Therapeutics and Revolution Medicines is -0.15 (i.e., Good diversification). The correlation of SpringWorks Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
SpringWorks Therapeutics Correlation With Market
Good diversification
The correlation between SpringWorks Therapeutics and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding SpringWorks Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
SpringWorks |
Moving together with SpringWorks Stock
| 0.69 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.68 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.67 | MNPR | Monopar Therapeutics | PairCorr |
Moving against SpringWorks Stock
| 0.68 | MDWD | Mediwound | PairCorr |
| 0.56 | VCEL | Vericel Corp Ord Earnings Call This Week | PairCorr |
| 0.56 | MLYS | Mineralys Therapeutics, | PairCorr |
| 0.4 | DRTS | Alpha Tau Medical | PairCorr |
| 0.33 | MLEC | Moolec Science SA | PairCorr |
| 0.32 | MIST | Milestone Pharmaceuticals | PairCorr |
| 0.5 | VIGL | Vigil Neuroscience | PairCorr |
| 0.39 | VIRX | Viracta Therapeutics | PairCorr |
| 0.33 | MRUS | Merus BV | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between SpringWorks Stock performing well and SpringWorks Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze SpringWorks Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RVMD | 1.95 | (0.17) | (0.07) | 0.06 | 2.53 | 3.61 | 18.30 | |||
| BPMC | 1.92 | 0.63 | 0.36 | 1.72 | 0.65 | 8.14 | 26.28 | |||
| STOK | 2.49 | 0.83 | 0.10 | (0.70) | 3.03 | 7.04 | 16.87 | |||
| CYTK | 2.24 | 0.00 | 0.00 | 0.24 | 0.00 | 4.24 | 16.73 | |||
| RLAY | 3.04 | 0.03 | 0.07 | 0.25 | 3.65 | 6.14 | 16.42 | |||
| IDYA | 2.42 | 0.42 | 0.05 | (25.67) | 3.45 | 6.69 | 15.53 | |||
| KYMR | 2.92 | 0.41 | 0.12 | 0.56 | 3.14 | 5.70 | 48.99 | |||
| CRNX | 2.22 | (0.42) | (0.06) | 0.03 | 3.05 | 4.17 | 15.86 | |||
| REPL | 4.98 | (0.80) | 0.00 | (0.17) | 0.00 | 11.15 | 89.28 |
SpringWorks Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SpringWorks Therapeutics stock to make a market-neutral strategy. Peer analysis of SpringWorks Therapeutics could also be used in its relative valuation, which is a method of valuing SpringWorks Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
SpringWorks Therapeutics Corporate Management
| Badreddin Edris | Chief Officer | Profile | |
| Mary Smith | Chief Officer | Profile | |
| Kim Diamond | Vice Relations | Profile | |
| James MD | Chief Officer | Profile | |
| Michael Nofi | Chief Officer | Profile | |
| TaiAn Lin | Chief Officer | Profile | |
| Saqib JD | CEO Director | Profile |
Still Interested in SpringWorks Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.